Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances bill letting pharmacists substitute therapeutically equivalent drugs to reduce delays
Summary
Senate Bill 482 would expand pharmacists’ authority to substitute therapeutically equivalent products (not just generic equivalents). Sponsors and pharmacists said the change reduces delays and prevents treatment interruptions; committee held the bill for revision after testimony.
PROVIDENCE, R.I. — The Senate Committee on Health and Human Services considered Senate Bill 482 on March 20, a measure that would explicitly permit pharmacists to substitute therapeutically equivalent drugs and therapeutically equivalent devices or supplies at the point of dispensing.
Sponsor Senator Lauria told the committee the change would allow pharmacists to make clinically appropriate interchanges — for example, switching among proton pump inhibitors or selecting a therapeutically equivalent inhaler — without delaying therapy while waiting for the…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
